Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythropoietin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00390832
What this trial is testing

Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)

Who this might be right for
Myocardial InfarctionAngioplasty, Transluminal, Percutaneous Coronary
Deutsches Herzzentrum Muenchen 138
Large-scale testing (Phase 3)Study completedNCT00270101
What this trial is testing

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Who this might be right for
AnemiaMultiple Myeloma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 156
Large-scale testing (Phase 3)Study completedNCT00354341
What this trial is testing

(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy

Who this might be right for
Anemia
Hoffmann-La Roche 170
Not applicableStudy completedNCT06877286
What this trial is testing

Low Sirtuin-1 Levels Are Linked to Erythropoietin Resistance in Hemodialysis Patients.

Who this might be right for
Chronic Kidney DiseaseHemodialysisAnemia in End Stage Renal Disease+1 more
Cuma Bulent Gul 391
Testing effectiveness (Phase 2)Ended earlyNCT01034657
What this trial is testing

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndrome (MDS)
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Study completedNCT01576341
What this trial is testing

HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease
Sandoz 417
Not applicableStudy completedNCT03861637
What this trial is testing

Impact of Full Correction of PTA in Renal Transplant Recipients

Who this might be right for
Anemia
Hamid Al-Essa Organ Transplant Center 280
Not applicableStudy completedNCT01126905
What this trial is testing

Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients

Who this might be right for
End-Stage Renal FailureFunctional Iron Deficiency
University of Ulster 250
Large-scale testing (Phase 3)Study completedNCT00598442
What this trial is testing

Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 493
Large-scale testing (Phase 3)Study completedNCT02390102
What this trial is testing

Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement

Who this might be right for
AnemiaAortic Stenosis
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 117
Not applicableUnknownNCT04573686
What this trial is testing

Prognostic Value of Serum Erythropoietin Level,Ferritin Level and Fibrinogen in Adult Low Risk MDS

Who this might be right for
MDS
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT02117427
What this trial is testing

TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal Disease
Aevi Genomic Medicine, LLC, a Cerecor company 11
Not applicableStudy completedNCT01393418
What this trial is testing

Evaluating Erythropoietin as an Indicator for Possible Kidney Injury After Cardiac Surgery

Who this might be right for
ErythropoietinAcute Kidney InjuryRenal Biomarker
University of Michigan 80
Early research (Phase 1)Study completedNCT01170078
What this trial is testing

A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment

Who this might be right for
Chronic Renal Failure
Hospira, now a wholly owned subsidiary of Pfizer 107
Testing effectiveness (Phase 2)Study completedNCT00752791
What this trial is testing

Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.

Who this might be right for
Anemia
Takeda 59
Large-scale testing (Phase 3)UnknownNCT00234143
What this trial is testing

Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
St. Bartholomew's Hospital 360
Testing effectiveness (Phase 2)Ended earlyNCT03140722
What this trial is testing

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 2
Not applicableStudy completedNCT00210951
What this trial is testing

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

Who this might be right for
Red-Cell Aplasia, PureChronic Renal Failure
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,761
Testing effectiveness (Phase 2)Study completedNCT00270010
What this trial is testing

Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

Who this might be right for
AnemiaAcquired Immunodeficiency Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72
Large-scale testing (Phase 3)Study completedNCT00270023
What this trial is testing

Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.

Who this might be right for
Blood TransfusionBlood Transfusion, AutologousOrthopedic Procedures+3 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 112
Next Page